This article was originally published in The Gray Sheet
U.S. Postal Service selects Cepheid's GeneXpert system for inclusion in initial $3.7 mil. pilot program evaluating the use of DNA-based tests for bio-threat detection. Based on results of the pilot, USPS plans to grant a multi-million dollar contract by the end of September to install DNA-based detection systems in all of its approximately 300 automatic mail-sorting facilities in the U.S. Of the initial program funding, Cepheid will receive about $750,000...
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.